首页> 外国专利> Antisense modulation of insulin-like growth factor binding protein 5 expressions

Antisense modulation of insulin-like growth factor binding protein 5 expressions

机译:胰岛素样生长因子结合蛋白5表达的反义调控

摘要

Provided is an antisense oligonucleotide 8 to 50 nucleobases in length targeted to nucleobases 11 through 30 or nucleobases 584 through 603 of a specified sequence of the nucleic acid molecule encoding insulin-like growth factor binding protein 5, wherein said oligonucleotide specifically hybridizes with one of said regions and inhibits the expression of insulin-like growth factor binding protein when the antisense molecule has at least a 70% complementary sequence to the said targeted nucleobases. The molecule can be used in vitro to inhibit the insulin-like growth factor binding protein 5 in cells or tissues.
机译:提供了靶向编码胰岛素样生长因子结合蛋白5的核酸分子的指定序列的核碱基11至30或核碱基584至603的长度为8至50个核碱基的反义寡核苷酸,其中所述寡核苷酸与所述寡核苷酸之一特异性杂交。当反义分子与所述靶向核碱基具有至少70%的互补序列时,该区域可抑制胰岛素样生长因子结合蛋白的表达并抑制其表达。该分子可以在体外用于抑制细胞或组织中的胰岛素样生长因子结合蛋白5。

著录项

  • 公开/公告号NZ577565A

    专利类型

  • 公开/公告日2010-10-29

    原文格式PDF

  • 申请/专利权人 ISIS PHARMACEUTICALS INC;

    申请/专利号NZ20020577565

  • 发明设计人 FREIER SUSAN M;

    申请日2002-10-07

  • 分类号C12Q1/68;A61K31/7088;A61K38/00;C07H21/04;C12N15/09;C12N15/11;

  • 国家 NZ

  • 入库时间 2022-08-21 18:45:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号